v3.25.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Revenues
Costs and expenses:    
Research and development costs 726,232 898,100
General and administrative costs 2,846,557 4,192,136
Total costs and expenses 3,572,789 5,090,236
Loss from operations (3,572,789) (5,090,236)
Interest income 7,048 17,486
Interest expense (16,821) (16,233)
Foreign currency gain (loss) (3,403) 1,954
Net loss $ (3,585,965) $ (5,087,029)
Net loss per common share basic $ (1.59) $ (2.66)
Net loss per common share diluted $ (1.59) $ (2.66)
Weighted average common shares outstanding basic 2,249,290 1,915,838
Weighted average common shares outstanding diluted 2,249,290 1,915,838

Source